Print page  Contact  Frontpage

Pipeline

 

7TM Pharma has a pipeline of discovery and development programs based on in-house research and development. The pipeline combines peptide and small molecule programs and includes two clinical programs both targeting the treatment of obesity, an indication within 7TM Pharmas focus on metabolic disorders. Additional drug discovery programs focus on novel treatments for inflammation (asthma/allergy), vascular diseases and metabolic disorders. 

 

 

Indication Target Discovery Pre-clinical
development
 
Phase I/II Phase IIa

Obesity/Metabolic disorders Y2+Y4  Obinepitide
Obesity/Metabolic disorders Y4

 TM30339

Obesity/Type-2 Diabetes
 
CB1  TM38837
Asthma/Allergy CRTH2

 Partner: JNJ

 

Peripheral Arterial Disease
Y2  
Liver fibrosis/ Obesity/ Type 2 Diabetes CB1  
Undisclosed target x

 Partner: Dr.Reddy's